Question 1

What is Canine Influenza Vaccine used for?

Accepted Answer

Canine Influenza Vaccine is indicated for: Canine influenza prevention, CIV H3N2 prevention (off-label).

Question 2

What routes can Canine Influenza Vaccine be administered by?

Accepted Answer

Available routes: SC.

Question 3

Which species have cited Canine Influenza Vaccine dosing data?

Accepted Answer

Canine Influenza Vaccine dosing in the ExoticRx formulary covers 2 species: Cat (Domestic), Dog (Domestic).

Question 4

Is Canine Influenza Vaccine a controlled substance?

Accepted Answer

Canine Influenza Vaccine is not federally scheduled as a controlled substance, but is veterinary prescription only in most jurisdictions.

Question 5

What are the warnings or contraindications for Canine Influenza Vaccine?

Accepted Answer

Two-dose primary series required. Recommended for dogs at high risk (boarding, shows, shelters). Mild injection site reactions possible.

Question 6

What are the side effects of Canine Influenza Vaccine?

Accepted Answer

Reported side effects, adverse reactions, and contraindications for Canine Influenza Vaccine: Two-dose primary series required. Recommended for dogs at high risk (boarding, shows, shelters). Mild injection site reactions possible.

Question 7

How does Canine Influenza Vaccine work?

Accepted Answer

Inactivated canine influenza virus H3N2 and H3N8 strains inducing protective antibody response. Does not prevent infection but reduces severity and shedding.

Species	Route	Dose	Frequency	Evidence	Source
Dog (Domestic)	SC	1 dose	2 doses 2-4 weeks apart; then annually	Moderate	AAHA Canine Vaccination Guidelines 2022
Cat (Domestic)	SC	1 dose	Not routinely recommended for cats	Anecdotal	AVMA/AAFP Reports on CIV in Cats

Canine Influenza Vaccine

Drug Class

Routes

Indications

Mechanism of Action

Side effects & warnings

Species with Canine Influenza Vaccine dosing data (2 dose rules)

Evidence levels across 2 dose rules

Backed by 2 published sources

Sample dosing (2 of 2 cited rules)

Upgrade for Full Details